Effectiveness and implementation of SHared decision-making supported by OUTcome information among patients with breast cancer, stroke and advanced kidney disease: SHOUT study protocol of multiple interrupted time series.

Mariska Quirina Nikita Hackert, Jet W Ankersmid, Noel Engels, Janine C M Prick, Steven Teerenstra, Sabine Siesling, Constance H C Drossaert, Luc J A Strobbe, Yvonne E A van Riet, René M A van den Dorpel, Willem Jan W Bos, Paul B van der Nat, Renske M van den Berg-Vos, Sander M van Schaik, Mirjam M Garvelink, Philip J van der Wees, Cornelia F van Uden-Kraan, Santeon VBHC breast cancer, stroke and chronic kidney disease group
Author Information
  1. Mariska Quirina Nikita Hackert: Santeon Hospital Group, Utrecht, The Netherlands m.hackert@santeon.nl. ORCID
  2. Jet W Ankersmid: Santeon Hospital Group, Utrecht, The Netherlands.
  3. Noel Engels: Santeon Hospital Group, Utrecht, The Netherlands. ORCID
  4. Janine C M Prick: Santeon Hospital Group, Utrecht, The Netherlands. ORCID
  5. Steven Teerenstra: Radboud Institute for Health Sciences, Health Evidence, section Biostatistics, Radboud University Medical Centre, Nijmegen, The Netherlands.
  6. Sabine Siesling: Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
  7. Constance H C Drossaert: Psychology, Health and Technology, University of Twente, Enschede, The Netherlands.
  8. Luc J A Strobbe: Surgical Oncology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  9. Yvonne E A van Riet: Surgical Oncology, Catharina Hospital, Eindhoven, The Netherlands.
  10. René M A van den Dorpel: Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
  11. Willem Jan W Bos: Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
  12. Paul B van der Nat: Value-Based Health Care, St. Antonius Hospital, Nieuwegein, The Netherlands.
  13. Renske M van den Berg-Vos: Neurology, OLVG, Amsterdam, The Netherlands.
  14. Sander M van Schaik: Neurology, OLVG, Amsterdam, The Netherlands.
  15. Mirjam M Garvelink: Value-Based Health Care, St. Antonius Hospital, Nieuwegein, The Netherlands.
  16. Philip J van der Wees: Radboud Institute for Health Sciences, Scientific Centre for Quality of Healthcare (IQ Healthcare), Radboud University Medical Centre, Nijmegen, The Netherlands.
  17. Cornelia F van Uden-Kraan: Santeon Hospital Group, Utrecht, The Netherlands.

Abstract

INTRODUCTION: Within the value-based healthcare framework, outcome data can be used to inform patients about (treatment) options, and empower them to make shared decisions with their health care professional. To facilitate shared decision-making (SDM) supported by outcome data, a multicomponent intervention has been designed, including patient decision aids on the organisation of post-treatment surveillance (breast cancer); discharge location (stroke) and treatment modality (advanced kidney disease), and training on SDM for health care professionals. The SHared decision-making supported by OUTcome information (SHOUT) study will examine the effectiveness of the intervention and its implementation in clinical practice.
METHODS AND ANALYSIS: Multiple interrupted time series will be used to stepwise implement the intervention. Patients diagnosed with either breast cancer (N=630), stroke (N=630) or advanced kidney disease (N=473) will be included. Measurements will be performed at baseline, three (stroke), six and twelve (breast cancer and advanced kidney disease) months. Trends on outcomes will be measured over a period of 20 months. The primary outcome will be patients' perceived level of involvement in decision-making. Secondary outcomes regarding effectiveness will include patient-reported SDM, decisional conflict, role in decision-making, knowledge, quality of life, preferred and chosen care, satisfaction with the intervention, healthcare utilisation and health outcomes. Outcomes regarding implementation will include the implementation rate and a questionnaire on the health care professionals' perspective on the implementation process.
ETHICS AND DISSEMINATION: The Medical research Ethics Committees United in Nieuwegein, the Netherlands, has confirmed that the Medical Research Involving Human Subjects Act does not apply to this study. Bureau Onderzoek & Innovatie of Santeon, the Netherlands, approved this study. The results will contribute to insight in and knowledge on the use of outcome data for SDM, and can stimulate sustainable implementation of SDM.
TRIAL REGISTRATION NUMBER: NL8374, NL8375 and NL8376.

Keywords

References

  1. Health Qual Life Outcomes. 2018 Feb 9;16(1):30 [PMID: 29471823]
  2. BMC Neurol. 2022 Jul 5;22(1):245 [PMID: 35790912]
  3. Health Serv Manage Res. 2022 Aug;35(3):189-193 [PMID: 33900128]
  4. Psychooncology. 2018 Nov;27(11):2609-2615 [PMID: 29843189]
  5. Health Informatics J. 2020 Jun;26(2):1194-1207 [PMID: 31566466]
  6. J Gen Intern Med. 2008 May;23(5):561-6 [PMID: 18335281]
  7. Support Care Cancer. 2019 Aug;27(8):2911-2920 [PMID: 30564933]
  8. Ann Intern Med. 2013 Feb 5;158(3):200-7 [PMID: 23295957]
  9. Implement Sci. 2016 Aug 08;11:114 [PMID: 27502770]
  10. Prev Sci. 2000 Mar;1(1):31-49 [PMID: 11507793]
  11. Patient Educ Couns. 2015 Oct;98(10):1172-9 [PMID: 26215573]
  12. Stroke. 2011 Aug;42(8):2276-9 [PMID: 21680905]
  13. Psychol Health. 2017 Apr;32(4):439-458 [PMID: 28052692]
  14. PLoS One. 2015 Jul 07;10(7):e0132158 [PMID: 26151946]
  15. Can J Nurs Res. 1997 Fall;29(3):21-43 [PMID: 9505581]
  16. J Cancer Surviv. 2022 Feb 4;: [PMID: 35122224]
  17. Med Care. 1996 Mar;34(3):220-33 [PMID: 8628042]
  18. Qual Life Res. 2009 Sep;18(7):873-80 [PMID: 19543809]
  19. Patient Educ Couns. 2010 Jul;80(1):94-9 [PMID: 19879711]
  20. Int J Qual Health Care. 2014 Oct;26(5):501-10 [PMID: 24951511]
  21. BMC Nephrol. 2022 Jul 6;23(1):236 [PMID: 35794539]
  22. Disabil Rehabil. 2012;34(6):478-85 [PMID: 21978031]
  23. Psychooncology. 2006 Apr;15(4):306-20 [PMID: 16041841]
  24. J Clin Oncol. 2020 May 20;38(15):1651-1654 [PMID: 32160103]
  25. Med Decis Making. 2014 Aug;34(6):699-710 [PMID: 23963501]
  26. BMC Health Serv Res. 2018 Dec 29;18(1):1005 [PMID: 30594193]
  27. Qual Life Res. 2011 Dec;20(10):1727-36 [PMID: 21479777]
  28. J Gen Intern Med. 2012 Oct;27(10):1361-7 [PMID: 22618581]
  29. N Engl J Med. 2016 Feb 11;374(6):504-6 [PMID: 26863351]
  30. Patient Educ Couns. 2021 Sep;104(9):2327-2337 [PMID: 33744056]
  31. Breast Cancer Res Treat. 2015 Aug;152(3):627-36 [PMID: 26162567]
  32. J Eval Clin Pract. 2020 Apr;26(2):524-540 [PMID: 31840346]
  33. J Psychosom Res. 2005 Jun;58(6):505-11 [PMID: 16125517]
  34. BMJ. 2013 Jan 08;346:e7586 [PMID: 23303884]
  35. Stat Med. 2010 Jul 30;29(17):1825-38 [PMID: 20658550]
  36. Patient Educ Couns. 2013 Oct;93(1):102-7 [PMID: 23768763]
  37. BMC Health Serv Res. 2020 Sep 14;20(1):862 [PMID: 32928203]
  38. N Engl J Med. 2010 Dec 23;363(26):2477-81 [PMID: 21142528]
  39. Value Health. 2016 Jun;19(4):343-52 [PMID: 27325326]
  40. Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431 [PMID: 28402085]
  41. Patient Educ Couns. 2022 Jul;105(7):2475-2479 [PMID: 35331573]
  42. J Gerontol. 1983 May;38(3):344-8 [PMID: 6841931]

MeSH Term

Breast Neoplasms
Decision Making
Decision Support Techniques
Female
Humans
Interrupted Time Series Analysis
Kidney Diseases
Patient Participation
Quality of Life
Stroke